FXR agonist GW4064 enhances anti-PD-L1 immunotherapy in colorectal cancer
Lu Lu(Fudan University), Lijun Zhang(Shanghai University of Traditional Chinese Medicine)
Cited by 20
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
|Nature Communications|2014|398
Mangiferin relieves CCl4-induced liver fibrosis in mice
|Scientific Reports|2023|73
Protein- and Peptide-Based Virus Inactivators: Inactivating Viruses Before Their Entry Into Cells
|Frontiers in Microbiology|2020|34